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Summary Helicobacterpylon (H. pylon) infection and intestinal metaplasia (IM) are each associated with an increased risk of gastric cancer
(GC). To explore further the influences of H. pylon and IM on GC, H. pylon and subtypes of IM were evaluated in 135 sex and age-matched
case and control pairs. Odds ratios (ORs) with 95% confidence intervals of developing GC were calculated for each risk factor using multiple
logistic regression analysis. ORs for H. pylon infection and IM were 2.43 (1.29-4.65) and 4.59 (2.58-8.16), respectively, and those for
different IM subtypes gave values of 0.82 (0.28-2.36) for type 1, 2.03 (0.95-4.34) for type 11 and 39.75 (14.34-110.2) for type Ill. Stratification
anatysis by histological subtype and stage of GC showed aparticularly high OR for IM in intestinal type (12.8, 4.73-34.83) and earty GC (6.40,
2.25-18.18). Our data indicate that both H. pylonand IM are related to GC risk. Type Ill IM is a more specific marker of premalignancy, with
relevance, in particular, to the earty and intestinal type of GC.
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Gastric cancer (GC) is one of the commonest cancers in the world
(Parkin et al. 1993) as well as in Taiwan (Wu et al. 1994). Despite
some improvement in its treatment. the 5-year survival rate of GC
remains low. Therefore. further exploration of biological features
and causes ofGC is needed to reduce its occurrence. Both environ-
mental and genetic factors are crucial in the multistage model of
gastric tumorigenesis (Correa. 1992). In sequential changes from
superficial gastritis to dysplasia and cancer. intestinal metaplasia
(TM) plays a pivotal role. This is testified by a high frequency ofIM
in patients with GC and in their relatives. a similar topographic
distribution of IM and GC. and a high IM occurrence in endemic
areas with a high risk ofGC (Dobrilla et al. 1994). Although most
investigators agree with Stemmermann (1994) thatthe riskofGC is
proportional to the extent of IM and although IM has been inten-
sively explored as a possible premalignant lesion of GC. contro-
versy exists because of many confounding factors in previous
retrospective studies (Antonioli. 1994). Because of the heteroge-
neous nature ofIM. a recent interest has been focused on the inter-
relationship between GC and different subtypes of IM (Jass et al.
1979: Turani et al. 1986: Filipe et al. 1994).
In recent years. abundant epidemiological data have consis-
tently documented a higher rate of H. pylor infection in GC
(Forman et al. 1991: Nomura et al. 1991: Parsonnet et al. 1991 ). H.
pylon-induced inflammation may facilitate gastric carcinogenesis
by increasing the rate ofcell replication. decreasing the concentra-
tion of ascorbic acid and inducing DNA damage via reactive
oxygen species (Sobala et al. 1993: Bechi et al. 1996). It is worth
noting that the prevalence ofIM is also closely related to H. pylon
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infection (Rugge et al. 1996). Furthermore. chronic aastritis due to
H. pylon infection may progress to LM and even GC (Correa.
1992: Dobrilla et al. 1994: StemmermTann. 1994). Nevertheless.
few studies are available to redefine the interactions of these two
factors with respect to gastric carcinogenesis. A preliminary obser-
vation has suggested that both IM and H. pylon infection are
important targets for prevention ofGC (Caselli. 1996). We under-
took this study to investigate the relations of H. pylon and of IM
and the risk ofGC.
MATERIALS AND METHODS
Patients and tissues
With their informed consent. a total of 160 patients with histo-
logically diagnosed GC were recruited consecutively for study
from January 1995 to January 1997. None of them received
chemotherapy before surgery. Tumours were classified as
intestinal or diffuse subtypes according to the Lauren criteria
(Lauren. 1965). The extent oftumour invasion was further divided
into early or advanced GC according, to the criteria proposed by
the Japanese Research Society for Gastric Cancer (Murakami.
1971). After excluding 25 patients with mixed or undetermined
histological subtypes of GC in gastrectomy specimens. 135
patients were finally included in this study. Tumorous. adjacent
and non-tumorous portions were resected from surgical specimens
and stored for further examination. Controls matched one-to-one
with cases on age (within 3 years). sex. ethnic group and residen-
tial area were also selected from subjects receiving endoscopic
examinations that did not reveal any ulcer nor tumour in the
stomach. During this procedure. five specimens were biopsied
including two from the lesser curvature of the antrum. one from
the incisura angularis and two from the lesser curvature of the
corpus ofthe stomach.
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Table 1 Frequency distribution of age, gender, ethnic group, H. pylon
infection and intestinal metaplasia of 135 matched pairs of gastic cancer
cases and controls
Variable Cases Control
n(%) n(%)
Age (year)
< 40 17 (12.6) 18 (13.3)
41-50 21 (15.6) 19 (14.1)
51-60 23 (17.0) 24 (17.8)
61-70 37 (27.4) 37 (27.4)
> 70 37 (27.4) 37 (27.4)
Gender
Male 71(52.6) 71(52.6)
Female 64 (47.4) 64 (47.4)
Ethnic group
Fukienese 109 (80.7) 109 (80.7)
Hakka 10 (7.4) 10 (7.4)
Other 16(11.9) 16(11 9)
H. pylona
Negative 49 (36.3) 60 (44.4)
Positive 86 (63.7) 75 (55.6)
Intestinal metaplasia
Negative 45 (33.3) 86 (63.7)
Positive 90 (66.7)t 49 (36.3)
Type 6 (4.4) 17 (12.6)
Type II 22 (16.3) 25 (18.5)
Type III 62 (46.0) 7 (5.2)
aSerological diagnosis by IgG antibodies to H. pylon. eP < 0.0001 vs controls.
Table 2 Histological features of diffuse and intestinal types of gastric cancer
Features Drns type Inesna type
(n=57) (n=78)
Depth of invasion
Earty 24 (42.1)a 23 (29.5)
Advanced 33 (57.9) 55 (70.5)
Adjacent metaplasia
Positive 19 (33.3)t 71 (91.0)
Negative 38 (66.7) 7 (9.0)
aNumbers in parentheses are percentages. hP < 0.0001 between diffuse and
intestinal type.
Serological tests for H. pylori
An aliquot of 5 ml of heparinized blood wvas collected from each
study subject. and the serum was separated on the same day and
stored at -70°C until further testing. The titre of serum IgG anti-
body against H. pylorn was determined using an enzyme-linked
immunosorbent assay as previously described (Lin et al. 1993).
Histopathological determination of intestinal
metaplasia and its subtypes
Specimens from patients and controls were fixed in 10% buffered
formalin. embedded in paraffin. sectioned and stained with haema-
toxylin and eosin (H&E). If IM was present in H&E staining, a
fther section was stained using the high iron diamine (HID)alcian
Table 3 Muftivanate-adjusted odds ratios of developing gastnc cancer for
H. pylon infection and intestinal metaplasia subtypes
Factors Adjusted odds ratios 95% Confidence intervals
H. pylon
Negative 1.00 Referent
Positive 2.43 1.29-4.65
Intestinal metaplasia
Negative 1.00 Referent
Positive
Type 0.82 0.28-2.36
Type II 2.03 0.95-4.34
Type III 39.75 14.34-110.20
1+11+111 4.59 2.58-8.16
blue (AB) technique (Lev. 1965). The HID/AB stain differentiates
acidic mucin into sialomucins (blue) and sulphomucins (brown-
black). Using HID/AB and H&E staining. the metaplastic lesions
were further classified into three subtypes: type I. i.e. complete IM
characterized by resembling normal intestinal epithelium: type II.
i.e. incomplete IM expressing sialomucins but not sulphomucins:
and type HII. i.e. incomplete IP expressing sulphomucins. If IM of
more than one subtype was present in a given sample. the case was
assigned to the least mature subtype. as proposed previously(Rugyge
et al. 1996).
Statistical analysis
Odds ratios (ORs). i.e. estimators of relative risk. and the corre-
sponding 95% confidence intervals (CI) of developinc GC were
calculated for each risk factor using multiple logistic regression
analysis (Breslow and Dav. 1980). Chi-square and Fisher's exact
tests were used to analyse categorical data. A P-value less than
0.05 was considered to be statistically significant.
RESULTS
The frequency distribution ofage. gender. ethnic groups. H.pylorn
infection and IM of GC patients and their matched controls is
shown in Table 1. The age distribution ofGC patients in this study
was similar to that previously reported in Taiwan (Wu et al. 1994).
Most study subjects were Fukienese. The frequency of H. pylori
infection was different between GC (63.7%c) and controls (55.6%7).
and the ORs (2.43. 95% CI 1.29-4.65) for H.pylori ofdeveloping
GC was significant after adjustment for IM. GC cases had a higher
frequency ofPM than controls (66.7%e xvs 36.3%. P < 0.0001).
The histological features of diffuse and intestinal type GC are
summarized in Table 2. There were 57 patients with diffuse type
GC and 78 with intestinal type GC. According to the depth of
invasion. the frequency ofearly lesion in diffuse type GC (42.1%)
was higher than that of intestinal type GC (29.5%7. P = 0.18).
Intestinal type GC had a significantly higher frequency of coexis-
tent IM (91.0%) than diffuse type (33.3%. P = 0.0001).
As shown in Table 3. ORs for H. pylori and IM of developing
GC were 2.43 (1.29-4.65) and 4.59 (2.58-8.16) respectively. A
significantly increased nrsk of GC was noted for type III IM (OR
39.75: 95% CI 14.34-110.20). The relationship between H. pylori
and GC after stratification by the presence or absence of IM is
summarized in Table 4. Seropositivity of H. pylori was less
frequent in type Ill IM (33 out of 62. 53.2%) than in type I plus
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Table 4 The relabonship between Helicobacterpylon seropostvity and
gastic cancer after stratificabon by the presence or absence of intesbnaJ
metaplasia
Gastrk cancer
Total H. pylon (+) Positve rate
ca number case number (%)
Intestinal metaplasia
Negative 45 31 68.9
Positive 90 55 61.1
Type 6 5 83.3
Typell 22 17 77.3
Type III 62 33 53-2t
aPositve IgG antibodies to H. pylon. "Type IlIl vs type + type II, P= 0.04
Tabie 5 Muttivanate-adjusted odds ratios of developing gastnc cancer for
intestinal metaplasia statfied by subtype and stage of gastric cancer
TypeStage Adusted odds ratio 95% Confidence interval
Intestinal type 12.83 4.73-34.83
Diffuse type 3.14 1.19-8.27
Early stage 6.40 2.25-18.18
Advanced stage 3.99 1.98-8.07
type H IM (22 out of 28. 78.6%c: P = 0.04). The odds ratios of
developing GC for NM in different histological subtypes and stages
of GC are shown in Table 5. All odds ratios were significant: a
particularly high OR was noted in the intestinal type GC (OR
12.83. 95%s CI 4.73-34.83).
DISCUSSION
In the multistep process of gastric carcinogenesis hypothesized by
Correa (1992). microenvironmental factors such as gastric atrophy
and IM have been identified. The recent discovery of H.pylori as
the main causative agent of gastritis leads many researchers to
investigate the association of H.pylori infection with development
of GC. It has been shown that H. pylori can increase the preva-
lence of IM (Rugge et al. 1996). In addition. prospective serolog-
ical studies have also reported a three- to sixfold increase ofrisk of
GC in H.pylori-infected individuals (Forman et al. 1991: Nomura
et al. 1991: Parsonnet et al. 1991). In the present study. an OR of
2.43 to contract GC for H.pylori-infected subjects was consistent
with those previously published. Collectively, these findings
support a widely accepted consensus that H.pylori is an important
environmental carcinogen for GC (Goldstone et al. 1996).
However. the mechanism by which H.pyloriinduces GC remains
ill-defined. H.pvlori-associatedchronic gastritis mayprovide aback-
ground forgastric tumorigenesis. in which the intestinal type may be
promoted in the atrophic stomach and the diffuse type in the non-
atrophic mucosa (Sipponen et al. 1992: Rubin. 1997). However. it
seems unlikely that H. pylon is solely responsible (Correa. 1992).
Recently. it has been shown that gastritis per se rather than its under-
lying causes may be a mnore dominant risk factor forGC (Sipponen et
al. 1992). Considerino the likehhood that H.pylon, age and NM may
be reciprocal confounding factors for GC. we have used a multiple
logistic regression analysis. which disclosed that both H.pylon and
NM were risk factors for GC. Different odds ratio in developing GC
for IM (OR 4.59) or for H. pylon infection (OR 2.43) were noted.
Our results support the aforementioned hypothesis that IM is a
precancerous lesion during the onset of GC (Sipponen et al. 1992:
Filipe et al. 1994). This notion is noteworthy because IM is the
advanced stage of gastritis and the risk factors for developing IM
resemble those fordeveloping GC (Correa et al. 1992: Dobrilla et al.
1994). Diets deficient in fresh fruits and vegetables. combined with a
high salt and nitrite intake. are common for both ofthese two condi-
tions (Correa et al. 1985: Stemmerman et al. 1990: Fuchs and
Mayers. 1995). Chronic gastritis due to H. pylor also precedes IM
and cancer (Sipponen et al. 1992: Goldstone et al. 1996). and accu-
mulating evidence has shown that geographic variation in diet may
influence the development of the intestinalized gastritis associated
w%ith GC (Stemmermann et al. 1990). Therefore. IM. reflecting the
duration and severity ofchronic gastritis as a result ofthe summation
ofall environmental insults. is a marker more specific for the precan-
cerous lesion of GC. Further studies are needed to ascertain the
concomitant relationship between H.pylori and other environmental
factors. e.g. dietary factors. in the pathogenesis of IM and GC.
Previous studies have noted a variable frequency of IM in GC
development (Stemmermann. 1994). One pathoepidemiological
study noted that the prevalence of NM was correlated more with
intestinal GC than with diffuse GC (Correa et al. 1970). Consistent
with this finding. our results also showed that IM was preferen-
tiaHly associated with intestinal GC (OR 12.83) but there was a
statistically insignificant difference between the ORs for intestinal
and diffuse cancers (OR 3.14). Furthermore. we noted that IM was
associated with early GC. as evidenced by a higher OR (6.40) than
with advanced GC (OR 3.99). but there was a statistically insignif-
icant difference between them. This finding supports the view-
point that IM per se is more crucial in the early carcinogenic
process. as similarly proposed by Solcia et al (1996). who reported
that IM is more frequently found in the gastric mucosae of early
rather than advanced cancer.
T1hree types of IM have been identified. according to the differ-
ences in enzyme production. mucus content and presence of
Paneth cells (Stemmermann et al. 1994). The different variants of
IM may exhibit different risks of GC development (Filipe et al.
1994): thus, type HI IM showed stronger risk of GC (OR 39.75)
than type H IM (OR 2.03). while type I had a low risk (OR 0.82).
The preferential association of type III N with GC supports the
notion that type IH IM is most often involved in the pathological
transition from dysplasia to carcinoma (Antonioli. 1994).
It is generaHly believed that IM develops in a background of
atrophic gastritis and. in such conditions. pre-existing, H. pylori
colonization of the stomach may be compromised (Forman et al.
1994). Mathialagan et al (1994) have demonstrated that the sero-
logical test only possesses a sensitivity of 59% in detecting H.
pylori infection for patients who have gastric atrophy. Our results
in Table 4 revealing a less frequent seropositivity of H. pylori in
GC associated with type II IM seemed to support the above
hypothesis. Similar results have been reported by Masci et al
(19%). who showed that the positive rate ofH.pyloriwas lower in
precancerous lesions. such as dysplasia. It highlighted the possi-
bility that the sensitivity of a serological test might be hampered
by the association of gastric atrophy and IM in GC and the role of
H.pylori might be underestimated.
In conclusion. our data indicate that both H. pylori and IM are
associated with risk ofdeveloping, GC and that they might be inter-
related. Furthermore. type HI IM is a more specific marker for a
British Joumal ofCancer(1998) 78(1), 125-128 0 CancerResearch Campaign 1998128 M-S Wu etal
premalignant lesion, especially with respect to early and
intestinal-type GC.
ABBREVIATIONS
GC, gastric cancer. IM. intestinal metaplasia; OR. odds ratio; Cl.
confidence interval
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